Novo Nordisk brings blockbuster weight-loss drug Ozempic to India

Danish drugmaker Novo Nordisk has launched its popular diabetes drug Ozempic in India. The drug is now available at a starting price of Rs 2,200. India has a significant number of people with type 2 diabetes and rising obesity. This makes it a key market for global drugmakers. Ozempic is a weekly injectable treatment for type 2 diabetes.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tvbRzVm
via IFTTT